Press release
Demand For Pharmacogenomic (Pgx) Testing Is Slated To Rise At An 8% CAGR Through 2028
Pharmacogenomic (PGx) Testing Market
The research report presents a comprehensive assessment of the Pharmacogenomic (PGx) Testing market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as those on the basis of geographies, applications, and industries.
๐๐ฒ๐ ๐๐๐๐๐ผ๐บ๐ถ๐๐ฎ๐๐ถ๐ผ๐ป ๐ผ๐ป ๐๐ต๐ถ๐ ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐ ๐ณ๐ผ๐ฟ ๐ฆ๐ฝ๐ฒ๐ฐ๐ถ๐ณ๐ถ๐ฐ ๐ฅ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต ๐ฆ๐ผ๐น๐๐๐ถ๐ผ๐ป๐:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=3143
๐๐ฒ๐ ๐ณ๐ถ๐ป๐ฑ๐ถ๐ป๐ด๐ ๐ผ๐ณ ๐๐ต๐ฒ ๐ฃ๐ต๐ฎ๐ฟ๐บ๐ฎ๐ฐ๐ผ๐ด๐ฒ๐ป๐ผ๐บ๐ถ๐ฐ (๐ฃ๐๐ ) ๐ง๐ฒ๐๐๐ถ๐ป๐ด ๐บ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐๐๐๐ฑ๐:
โข The report provides a present market outlook on Low-Calorie Margarine. Additionally, the Low-Calorie Margarine market share is anticipated to grow with a CAGR of 5.5% in the forecast period.
โข Regional breakdown of the Pharmacogenomic (PGx) Testing market based on predefined taxonomy.
โข Innovative manufacturing processes implemented by Pharmacogenomic (PGx) Testing vendors in detail.
โข Region-wise and country-wise fragmentation of the Pharmacogenomic (PGx) Testing market to grasp the revenue, and growth outlook in these areas.
โข Changing preferences among consumers across various regions and countries.
โข Factors (Positive and Negative) impacting the growth of the global Pharmacogenomic (PGx) Testing market.
โข Pharmacogenomic (PGx) Testing price, market share, and Trends forecast for assessment period 2018-2028
๐ฃ๐ต๐ฎ๐ฟ๐บ๐ฎ๐ฐ๐ผ๐ด๐ฒ๐ป๐ผ๐บ๐ถ๐ฐ (๐ฃ๐๐ ) ๐ง๐ฒ๐๐๐ถ๐ป๐ด ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐: ๐ฆ๐ฒ๐ด๐บ๐ฒ๐ป๐๐ฎ๐๐ถ๐ผ๐ป
The global pharmacogenomic (PGx) testing market is segmented based on the by test type, application, end user and region
๐๐ ๐๐ฒ๐๐ ๐๐๐ฝ๐ฒ ๐ฝ๐ต๐ฎ๐ฟ๐บ๐ฎ๐ฐ๐ผ๐ด๐ฒ๐ป๐ผ๐บ๐ถ๐ฐ (๐ฃ๐๐ ) ๐๐ฒ๐๐๐ถ๐ป๐ด ๐บ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ถ๐ ๐๐ฒ๐ด๐บ๐ฒ๐ป๐๐ฒ๐ฑ ๐ฎ๐:
โข Therapeutic Tests
โข Diagnostic Tests
๐๐ ๐ฎ๐ฝ๐ฝ๐น๐ถ๐ฐ๐ฎ๐๐ถ๐ผ๐ป, ๐๐ต๐ฒ ๐ด๐น๐ผ๐ฏ๐ฎ๐น ๐ฝ๐ต๐ฎ๐ฟ๐บ๐ฎ๐ฐ๐ผ๐ด๐ฒ๐ป๐ผ๐บ๐ถ๐ฐ (๐ฃ๐๐ ) ๐๐ฒ๐๐๐ถ๐ป๐ด ๐บ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ถ๐ ๐๐ฒ๐ด๐บ๐ฒ๐ป๐๐ฒ๐ฑ ๐ฎ๐:
โข Oncology
โข Cardiovascular
โข Others
๐๐ ๐ฒ๐ป๐ฑ ๐๐๐ฒ๐ฟ, ๐ด๐น๐ผ๐ฏ๐ฎ๐น ๐ฝ๐ต๐ฎ๐ฟ๐บ๐ฎ๐ฐ๐ผ๐ด๐ฒ๐ป๐ผ๐บ๐ถ๐ฐ (๐ฃ๐๐ ) ๐๐ฒ๐๐๐ถ๐ป๐ด ๐บ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ถ๐ ๐๐ฒ๐ด๐บ๐ฒ๐ป๐๐ฒ๐ฑ ๐ฎ๐:
โข Diagnostic Laboratories
โข Research Laboratories
โข Academic Research Institutes
๐ง๐ผ ๐ฟ๐ฒ๐ฐ๐ฒ๐ถ๐๐ฒ ๐ฒ๐ ๐๐ฒ๐ป๐๐ถ๐๐ฒ ๐น๐ถ๐๐ ๐ผ๐ณ ๐ถ๐บ๐ฝ๐ผ๐ฟ๐๐ฎ๐ป๐ ๐ฟ๐ฒ๐ด๐ถ๐ผ๐ป๐, ๐ฎ๐๐ธ ๐ณ๐ผ๐ฟ ๐ง๐ข๐ ๐ต๐ฒ๐ฟ๐ฒ -https://www.factmr.com/connectus/sample?flag=T&rep_id=3143
๐ช๐ต๐ฎ๐ ๐บ๐ฎ๐ธ๐ฒ๐ ๐๐ต๐ถ๐ ๐ฅ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต ๐ฑ๐ถ๐ณ๐ณ๐ฒ๐ฟ๐ฒ๐ป๐ ๐ณ๐ฟ๐ผ๐บ ๐ผ๐๐ต๐ฒ๐ฟ๐?
โข COVID- Impact analysis- The report includes details of the impact of the pandemic on the Pharmacogenomic (PGx) Testing market further including insights on the pre-COVID situation. Additionally, this report benefits in terms of post-COVID recovery prospects, changing consumer demands, and buying patterns valuable for Pharmacogenomic (PGx) Testing companies.
โข Industrial trend analysis- The research covers recent trends in the field of Pharmacogenomic (PGx) Testing which are augmented with the applicable technologies and shifts in industrial processes. The scope for digital and industrial technologies is discussed in order to help client firms to understand the benefits and risks included in light of market trends.
โข Pharmacogenomic (PGx) Testing Sustainability metrics- The rising concerns of environmentally friendly production and consumption are taken to next level in this research, as research is focused on emerging methods of ensuring sustainability. These insights include climate-friendly initiatives adopted by some players in the industry. Furthermore, details of manufacturers' impact on carbon footprint are evaluated intend to make clients aware of their contribution to sustainable development goals.
๐๐ผ๐บ๐ฝ๐ฒ๐๐ถ๐๐ถ๐๐ฒ ๐๐ฎ๐ป๐ฑ๐๐ฐ๐ฎ๐ฝ๐ฒ
The Pharmacogenomic (PGx) Testing industry is dominated by some prominent players including
Affymetrix, Inc., Becton Dickinson and Company, Bayer AG, Abbott Laboratories, Inc., Thermo Fisher Scientific Inc., AstraZeneca PLC, QIAGEN and others
The competition in the sector is driven by key parameters such as product price, targeted customer base, and strategic marketing. Major players in the market focused on the Pharmacogenomic (PGx) Testing market innovation by investing more in research and development. Furthermore, the industry players are focusing on the extensive usage of online distribution channels for enhanced cost-effectiveness. The sustainability in the supply chain is a decisive factor for Pharmacogenomic (PGx) Testing brands leading to an impact on the margin profits of firms.
๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐ ๐๐ฒ๐ป๐ฒ๐ณ๐ถ๐๐ & ๐๐ฒ๐ ๐ค๐๐ฒ๐๐๐ถ๐ผ๐ป๐ ๐๐ป๐๐๐ฒ๐ฟ๐ฒ๐ฑ
โข Pharmacogenomic (PGx) Testing Company & brand share analysis: Company and brand share analysis on Pharmacogenomic (PGx) Testing reveals how much market share is captured by Tier 1, Tier 2, and Tier 3 players
โข Pharmacogenomic (PGx) Testing Historical volume analysis: The industry analysis provides data & insights on historical volume sales of Pharmacogenomic (PGx) Testing
โข Pharmacogenomic (PGx) Testing Category & segment level analysis: Fact.MR's Pharmacogenomic (PGx) Testing sales outlook offers category and segment level analysis on lucrative and nascent product types. Market players can use this information to identify sales potential and set sales targets at local, country, and regional level.
โข Pharmacogenomic (PGx) Testing Consumption by demographics: The market intelligence study provides consumption by demographics analysis so market players can design their product and marketing strategies on the basis of high-value consumers
โข Post COVID consumer spending on Pharmacogenomic (PGx) Testing: The report includes post COVID consumer spending analysis. This information will help business leads understand the shifts in purchasing power and behavior
โข Manufacturing trend analysis: Vital information on how market players are aligning their manufacturing strategies with respect to evolving consumer sentiments
๐๐ผ๐ฟ ๐ถ๐ป-๐ฑ๐ฒ๐ฝ๐๐ต ๐ฐ๐ผ๐บ๐ฝ๐ฒ๐๐ถ๐๐ถ๐๐ฒ ๐ฎ๐ป๐ฎ๐น๐๐๐ถ๐, ๐๐๐ ๐ก๐ผ๐ -https://www.factmr.com/checkout/3143
๐ช๐ต๐ ๐ฐ๐ต๐ผ๐ผ๐๐ฒ ๐๐ฎ๐ฐ๐.๐ ๐ฅ?
Reports published by Fact.MR are a result of the combination of our experts and digital technologies. We thrive to provide innovative business solutions to the clients as well as tailor the reports aligning with the clients' requisites. Our analysts perform comprehensive research to offer ins and outs of the current market situation. Clients across various time zones tend to utilize our 24/7 service availability.
๐๐ผ๐ฟ ๐ ๐ผ๐ฟ๐ฒ ๐๐ป๐๐ถ๐ด๐ต๐๐:
https://www.prnewswire.com/news-releases/how-bobcat-emea-region-boosted-up-their-skid-steer-loader-sales-by-12-7-factmr-301217359.html
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com
About Us:
Market research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range - from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we'll be an able research partner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Demand For Pharmacogenomic (Pgx) Testing Is Slated To Rise At An 8% CAGR Through 2028 here
News-ID: 2842941 • Views: โฆ
More Releases from Fact.MR
E-Beam Wafer Inspection System Market is Expected to Progress at a CAGR of 18.3% โฆ
The global e-beam wafer inspection system market is projected to increase from USD 862.5 million in 2025 to USD 4,630.3 million by 2035, with a CAGR of 18.3% during the forecast period. Growth is driven by rising demand for high-quality semiconductor wafers fueled by advanced electronic devices and emerging technologies.
E-beam wafer inspection systems are ideal for their ability to provide ultra-high-resolution nanoscale defect detection, down to 1-2 nanometers, enabling preciseโฆ
Fire Pits Market is Poised to Grow at a CAGR of 3.5% to Reach US$ 217.1 Million โฆ
The global fire pits market is forecast to reach USD 217.1 million by 2035, up from USD 153.9 million in 2025. During the forecast period, the industry is projected to register a CAGR of 3.5%.
Increasing outdoor living investments as homeowners seek better leisure spaces are driving the fire pits market. Consumers are increasingly incorporating fire pits into gardens, patios, and backyard spaces to create inviting, cozy environments for social gatheringsโฆ
Drone Battery Industry Analysis in Europe is Predicted to Reach US$ 4.31 Billion โฆ
According to the latest study published by Fact.MR, demand for drone batteries in Europe is estimated at a market value of US$ 2.03 billion in 2024. The European market is projected to expand at a CAGR of 7.8% and reach US$ 4.31 billion by the end of 2034.
Increasing demand for drones in several use cases, including photography, construction, agriculture, delivery, and surveillance, is set to drive the sales of long-lastingโฆ
North America Cosmetic Dropper Market to Reach 4.1% CAGR by 2035, Driven by Prem โฆ
The global cosmetic dropper market is poised for significant growth, driven by evolving consumer preferences and advancements in packaging technologies. The market is projected to expand from USD 98.6 million in 2025 to USD 185.1 million by 2035, registering a compound annual growth rate (CAGR) of 6.5% during this period. This growth reflects an increasing demand for cosmetic products that combine functionality, aesthetics, and convenience.
For More Insights into the Market,โฆ
More Releases for PGx
Pharmacogenomics (PGX) Market Key Innovations 2025-2032
The Pharmacogenomics (PGX) market is at the forefront of a transformative wave in personalized medicine, revolutionizing how healthcare professionals approach treatment plans based on individual genetic profiles. PGX merges pharmacology and genomics to tailor drug therapies, enhancing efficacy and minimizing adverse effects. As the healthcare landscape evolves, the demand for PGX solutions is surging, driven by a growing emphasis on precision medicine, which seeks to optimize therapeutic outcomes for patients.
Recentโฆ
Pharmacogenomics (PGx) Market Size, Trends 2031 By Key Players- Abbott Laborator โฆ
๐๐๐, ๐๐๐ฐ ๐๐๐ซ๐ฌ๐๐ฒ: According to Verified Market Reports analysis, the global Pharmacogenomics (PGx) Market size was valued at USD 16.5 Billion in 2023 and is projected to reach USD 32.1 Billion By 2031, growing at a CAGR of 9.17% during the forecast period 2024 to 2031.
The Pharmacogenomics (PGx) Market presents significant opportunities for growth driven by the increasing demand for personalized medicine and advancements in genomic technologies. Pharmacogenomics, which studiesโฆ
Pharmacogenomics (PGx) Market Skyrocketing Revenue Growth of USD 11.63 Billion, โฆ
The global Pharmacogenomics (PGx) Market is expected to grow from USD 6.73 billion in 2020 to USD 11.63 billion by 2030, at a CAGR of +7% during the forecast period 2022-2030.
Pharmacogenomics (PGx), is the study of how people respond differently to drug therapy based upon their genetic makeup. Pharmacogenomics is part of the field of precision medicine, which aims to treat each patient individually. It uses genomic information to studyโฆ
Pharmacogenomics (PGx) Market with High Grow in CAGR of +8% with Prominent Key P โฆ
According to The Global Market Vision, the Latest research report on "Pharmacogenomics (PGx) Market size accounted for $5,312.8 million in 2022 and is projected to reach $10,265.5 million by 2030, registering a CAGR of +8% from 2022 to 2030.
The increase in the elderly population, the surge in the adoption of pharmacogenomics procedures by healthcare professionals, growing awareness of the patient population towards personalized therapy, and growth in prevalence of chronicโฆ
Global Pharmacogenomics (PGx) Market 2022 Key Indicators - Abbott Laboratories, โฆ
The market study based on the Global Pharmacogenomics (PGx) Market published byย The Brainy Insightsย provides an up-to-date and accurate market picture. It also provides important data on the various components which affect the progress of the Pharmacogenomics (PGx) market through a brief scan and detailed information. The report will help stakeholders and partners define the best development methods and take advantage of the opportunities prevailing in the Pharmacogenomics (PGx) market. Aโฆ
Pharmacogenomic (PGx) Testing Market Globally Expected to Drive Growth through 2 โฆ
Pharmacogenomic (PGx) testing is study of the effect of individual genetic make-up on the therapeutic effect of the medication. The individual response to the medication is determined by the various factor such as weight, age, diet, habits, and genetic factors, etc.
The genetic make-up of the individual majorly decides the metabolism rate of the medication along with other factors. Depending on the variation in person to person gene make-up, metabolism ofโฆ
